These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29870976)

  • 101. [Analysis of clinical data, esophageal motility and reflux characteristics in patients with non-erosive reflux disease(NERD) and reflux esophagitis(RE)].
    Wang HF; Liu F; Wang M; Du SY; Zhang YL
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(20):1605-1608. PubMed ID: 29886654
    [No Abstract]   [Full Text] [Related]  

  • 102. Tegoprazan to treat gastroesophageal reflux disease.
    Mermelstein J; Mermelstein AC; Chait MM
    Drugs Today (Barc); 2020 Nov; 56(11):715-721. PubMed ID: 33332479
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test.
    Masaoka T; Kameyama H; Yamane T; Yamamoto Y; Takeuchi H; Suzuki H; Kitagawa Y; Kanai T
    J Neurogastroenterol Motil; 2018 Oct; 24(4):577-583. PubMed ID: 30347936
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Lesser known aspects of gastroesophageal reflux disease: non-acid reflux and functional pyrosis].
    Garrigues V; Ponce J
    Gastroenterol Hepatol; 2008 Oct; 31(8):522-9. PubMed ID: 18928753
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.
    Viazis N; Keyoglou A; Kanellopoulos AK; Karamanolis G; Vlachogiannakos J; Triantafyllou K; Ladas SD; Karamanolis DG
    Am J Gastroenterol; 2012 Nov; 107(11):1662-7. PubMed ID: 21625270
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Curry induces acid reflux and symptoms in gastroesophageal reflux disease.
    Lim LG; Tay H; Ho KY
    Dig Dis Sci; 2011 Dec; 56(12):3546-50. PubMed ID: 21735083
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications.
    Kleiman DA; Sporn MJ; Beninato T; Metz Y; Crawford C; Fahey TJ; Zarnegar R
    Surg Endosc; 2013 Apr; 27(4):1302-9. PubMed ID: 23232999
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis.
    Oshima T; Igarashi A; Nakano H; Deguchi H; Fujimori I; Fernandez J
    J Clin Gastroenterol; 2022 Jul; 56(6):493-504. PubMed ID: 35470298
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
    Iwakiri K; Fujiwara Y; Manabe N; Ihara E; Kuribayashi S; Akiyama J; Kondo T; Yamashita H; Ishimura N; Kitasako Y; Iijima K; Koike T; Omura N; Nomura T; Kawamura O; Ohara S; Ozawa S; Kinoshita Y; Mochida S; Enomoto N; Shimosegawa T; Koike K
    J Gastroenterol; 2022 Apr; 57(4):267-285. PubMed ID: 35226174
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.
    Scarpignato C; Hunt RH
    Curr Opin Gastroenterol; 2019 Jul; 35(4):344-355. PubMed ID: 31045597
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Diagnosis and treatment of NERD (non-erosive reflux disease)].
    Kinoshita Y; Furuta K; Adachi K
    Nihon Shokakibyo Gakkai Zasshi; 2005 Nov; 102(11):1377-83. PubMed ID: 16318376
    [No Abstract]   [Full Text] [Related]  

  • 112. Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy: is gastroparesis a factor?
    Tavakkoli A; Sayed BA; Talley NJ; Moshiree B
    World J Gastroenterol; 2013 Oct; 19(37):6193-8. PubMed ID: 24115816
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Reflux Symptoms in Gastroparesis: Correlation With Gastroparesis Symptoms, Gastric Emptying, and Esophageal Function Testing.
    Jehangir A; Parkman HP
    J Clin Gastroenterol; 2020; 54(5):428-438. PubMed ID: 30762609
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings.
    Sifrim D; Holloway R; Silny J; Xin Z; Tack J; Lerut A; Janssens J
    Gastroenterology; 2001 Jun; 120(7):1588-98. PubMed ID: 11375941
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [An analysis of persistent symptoms in acid-suppressed patients with non-erosive reflux disease undergoing esophageal pH-impedance monitoring].
    Iwakiri K; Sano H; Tanaka Y; Kawami N; Umezawa M; Iizumi T; Futagami S; Hoshihara Y; Nomura T; Miyashita M; Sakamoto C
    Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):538-48. PubMed ID: 20379089
    [No Abstract]   [Full Text] [Related]  

  • 116. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis.
    Barlow WJ; Orlando RC
    Gastroenterology; 2005 Mar; 128(3):771-8. PubMed ID: 15765412
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Strategy for treatment of nonerosive reflux disease in Asia.
    Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
    World J Gastroenterol; 2008 May; 14(20):3123-8. PubMed ID: 18506915
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients.
    Oridate N; Takeda H; Asaka M; Nishizawa N; Mesuda Y; Mori M; Furuta Y; Fukuda S
    Dig Dis Sci; 2008 Aug; 53(8):2033-8. PubMed ID: 18080197
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms.
    Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K
    J Gastroenterol; 2021 Feb; 56(2):117-124. PubMed ID: 33247348
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Distinction between patients with non-erosive reflux disease and functional heartburn.
    Giacchino M; Savarino V; Savarino E
    Ann Gastroenterol; 2013; 26(4):283-289. PubMed ID: 24714313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.